Long-term survival and interruption of HAART in HIV-related pulmonary hypertension.
Eur J Clin Microbiol Infect Dis
; 24(2): 153-5, 2005 Feb.
Article
en En
| MEDLINE
| ID: mdl-15711784
Reported here is a case of a patient with pulmonary arterial hypertension related to HIV (PAHRH) in which lipodystrophy necessitated interruption of highly active antiretroviral therapy (HAART) and long-term survival was the outcome. Although previous studies have suggested antiretroviral therapy may benefit patients with this rare complication of HIV infection, no worsening of PAHRH was observed when HAART was interrupted. Clinical and echocardiographic parameters remained stable during 7 months of follow up. In cases in which HAART is associated with relevant toxicity, interruption of HAART in patients with PAHRH can be considered, but should be used only if no alternatives are available. Close follow-up is warranted.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por VIH
/
Terapia Antirretroviral Altamente Activa
/
Hipertensión Pulmonar
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Eur J Clin Microbiol Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
/
MICROBIOLOGIA
Año:
2005
Tipo del documento:
Article
País de afiliación:
Suiza
Pais de publicación:
Alemania